Society of Nuclear Medicine
Molecular imaging links systemic inflammation with depression
New research published in the April issue of The Journal of Nuclear Medicine reveals that systemic inflammation causes an increase in depressive symptoms and metabolic changes in the parts of the brain responsible for mo ...
Neuroscience
Apr 02, 2012 |
4.8 / 5 (6) |
0
New skin patch treatment kills most common form of skin cancer
A customized patch treatment for basal cell carcinoma completely destroys facial tumors without surgery or major radiation therapy in 80 percent of patients studied, say researchers at the Society of Nuclear Medicine's 2012 ...
Cancer
Jun 11, 2012 |
4.5 / 5 (4) |
0
Benefits of radionuclide therapy for neuroendocrine tumors
According to new Dutch research featured in the September issue of The Journal of Nuclear Medicine, a peptide receptor radiolabeled therapy (PRRT), [177Lu-DOTA0,Tyr3]Octreotate (177Lu-octreotate) , is effective not only i ...
Cancer
Sep 20, 2011 |
5 / 5 (2) |
1
Bioluminescence imaging lights up stem cell therapy for hair growth
Finding a way to restore hair growth after substantial hair loss is something of an obsession worldwide. Investigators at the Society of Nuclear Medicine's 2012 Annual Meeting presented how stem cell research for the development ...
Medical research
Jun 11, 2012 |
5 / 5 (2) |
0
Molecular imaging shows chronic marijuana smoking affects brain chemistry
Definitive proof of an adverse effect of chronic marijuana use revealed at SNM's 58th Annual Meeting could lead to potential drug treatments and aid other research involved in cannabinoid receptors, a neurotransmission system ...
Neuroscience
Jun 06, 2011 |
3 / 5 (2) |
0
Combined imaging agents advance PET imaging of cancer
Research presented at SNM's 58th Annual Meeting is taking targeted molecular imaging to a new level by combining two commonly used imaging agents into one molecular imaging procedure. The combination of these agents creates ...
Cancer
Jun 06, 2011 |
5 / 5 (1) |
0
High-impact radiopeptide therapy halts neuroendocrine cancer
Research introduced at SNM's 58th Annual Meeting could be a sign of hope for patients with neuroendocrine cancer not responding well to standard therapies. Most radiotherapies use medical isotopes that emit beta radiation. ...
Cancer
Jun 06, 2011 |
5 / 5 (1) |
0
New pretargeted radioimmunotherapy for colorectal cancer
Investigators at SNM's 58th Annual Meeting are presenting results from a phase 1 clinical trial for a cancer therapy that has the potential to kill colorectal tumors with less destruction of healthy tissue. Further research ...
Cancer
Jun 06, 2011 |
5 / 5 (1) |
0
A decade of research proves PET effectively detects dementia
In a new review of imaging studies spanning more than ten years, scientists find that a method of positron emission tomography (PET) safely and accurately detects dementia, including the most common and devastating form among ...
Diseases, Conditions, Syndromes
Jan 06, 2012 |
5 / 5 (1) |
0
Cocaine vaccine gets a boost with molecular imaging
Addicts unable to kick a cocaine habit could one day be vaccinated against cocaine and see proof with a molecular imaging technique that shows how the vaccine prompts antibodies to whisk away the drug before it can reach ...
Medical research
Jun 11, 2012 |
5 / 5 (1) |
0
PET predicts early response to treatment for head and neck cancer patients
Determining the optimal treatment course and predicting outcomes may get easier in the future for patients with head and neck sqaumous cell carcinomas (HNSCCs) with the use of an investigational imaging agent. Research published ...
Cancer
Oct 01, 2012 |
5 / 5 (1) |
0
Molecular imaging finds link between low dopamine levels and aggression
Out of control competitive aggression could be a result of a lagging neurotransmitter called dopamine, say researchers presenting a study at the Society of Nuclear Medicine's 2012 Annual Meeting. During a computer game against ...
Psychology & Psychiatry
Jun 11, 2012 |
1 / 5 (1) |
0
